Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States.

[1]  M. Vaduganathan,et al.  Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction. , 2021, Journal of the American College of Cardiology.

[2]  D. Fischman,et al.  Sex-Based Differences in Prevalence and Outcomes of Common Acute Conditions Associated with Type 2 Myocardial Infarction. , 2021, The American journal of cardiology.

[3]  M. Vaduganathan,et al.  Cardiologist Evaluation of Patients with Type 2 Myocardial Infarction. , 2020, Circulation. Cardiovascular quality and outcomes.

[4]  M. Vaduganathan,et al.  Home‐Time After Discharge Among Patients With Type 2 Myocardial Infarction , 2020, Journal of the American Heart Association.

[5]  A. Villringer,et al.  Brain Damage With Heart Failure , 2020, Circulation research.

[6]  H. Krumholz,et al.  Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States , 2020, BMJ.

[7]  D. Morrow,et al.  Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury , 2019, Circulation.

[8]  W. Aronow,et al.  Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes. , 2019, American heart journal.

[9]  M. Vaduganathan,et al.  Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs. , 2019, JAMA cardiology.

[10]  A. Jaffe,et al.  Type 2 Myocardial Infarction: JACC Review Topic of the Week. , 2019, Journal of the American College of Cardiology.

[11]  Saul Blecker,et al.  Trends in Hospital Readmission of Medicare-Covered Patients With Heart Failure. , 2019, Journal of the American College of Cardiology.

[12]  R. Starling,et al.  Heart Failure and Liver Disease: Cardiohepatic Interactions. , 2019, JACC. Heart failure.

[13]  S. Haneuse,et al.  Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia , 2018, JAMA.

[14]  Yuling Hong,et al.  National Burden of Heart Failure Events in the United States, 2006 to 2014 , 2018, Circulation. Heart failure.

[15]  Jeroen J. Bax,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Circulation.

[16]  M. Vaduganathan,et al.  Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. , 2018, Journal of the American College of Cardiology.

[17]  G. Fonarow,et al.  Impact of end stage renal disease on in-hospital outcomes of patients with systolic and diastolic heart failure (insights from the Nationwide Inpatient Sample 2010 to 2014). , 2018, International journal of cardiology.

[18]  Deepak L. Bhatt,et al.  Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction. , 2018, JACC. Heart failure.

[19]  P. Kaul,et al.  Impact of Type 2 Myocardial Infarction (MI) on Hospital‐Level MI Outcomes: Implications for Quality and Public Reporting , 2018, Journal of the American Heart Association.

[20]  S. Russell,et al.  Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005–2014): ARIC Study Community Surveillance , 2018, Circulation.

[21]  E. Simões,et al.  The economic case for US hospitals to revise their approach to heart failure readmission reduction. , 2018, Annals of translational medicine.

[22]  D. Mozaffarian,et al.  National Trends in Admission and In‐Hospital Mortality of Patients With Heart Failure in the United States (2001–2014) , 2017, Journal of the American Heart Association.

[23]  D. Newby,et al.  Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury , 2017, Circulation.

[24]  R. Yeh,et al.  Comparison of 30-Day Readmission Rates After Hospitalization for Acute Myocardial Infarction in Men Versus Women. , 2017, The American journal of cardiology.

[25]  P. Austin,et al.  Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure. , 2017, JACC. Heart failure.

[26]  R. Matsukawa,et al.  Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure. , 2017, Journal of the American College of Cardiology.

[27]  Wing W. Chan,et al.  Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality. , 2015, The American journal of cardiology.

[28]  S. Normand,et al.  Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011 , 2014, Circulation.

[29]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[30]  A. Sarría-Santamera,et al.  Risk factors for hospital readmissions in elderly patients: a systematic review. , 2011, QJM : monthly journal of the Association of Physicians.

[31]  Deepak L. Bhatt,et al.  Discharge to a Skilled Nursing Facility and Subsequent Clinical Outcomes Among Older Patients Hospitalized for Heart Failure , 2011, Circulation. Heart failure.

[32]  P. Heidenreich,et al.  Characteristics and Outcomes of Very Elderly Patients After First Hospitalization for Heart Failure , 2011, Circulation. Heart failure.

[33]  M. Pfeffer,et al.  Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program , 2009, European journal of heart failure.

[34]  S. Solomon,et al.  Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. , 2008, European heart journal.

[35]  G. Fonarow,et al.  Cardiac troponin and outcome in acute heart failure. , 2008, The New England journal of medicine.

[36]  G. Fonarow,et al.  Epidemiology and risk stratification in acute heart failure. , 2008, American heart journal.

[37]  P. Patel,et al.  Trends and Predictors of 30-day readmission in Patients with Heart Failure , 2016 .